1. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J. Clin. Sleep. Med. 2017 Feb 15;13(2):307–349. DOI: 10.5664/jcsm.6470
2. Zakharov A. V., Khivintseva E. V. Clinical Use of Melatonin in the Treatment of Sleep Disorders. Effective pharmacotherapy. 2019. V. 15. No. 44. P. 42–47. DOI 10.33978/2307–3586–2019–15–44–42–47
3. Poluektov MG. [Origin and treatment of insomnia: current status of knowledge]. Ross Fiziol Zh Im I M Sechenova. 2012 Oct;98(10):1188–99. Russian. PMID: 23401914.
4. Oganesyan G.A., Aristakesyan Ye.A., Romanova I.V., Vatayev S.I., Kuzik V.V., Kambarova D.K. Evolutionary aspects of the slep-wakefulness cycle. Part 2: Neuromediator mechanisms of its regulation. Biosfera. 2011. Vol. 5. No. 1. 97–123. URL: https://cyberleninka.ru/article/n/voprosy-evolyutsii-tsikla-bodrstvovanie-son-chast2-neyromediatornye-mehanizmy-regulyatsii (дата обращения: 17.11.2022).
5. Burchinsky S.G. Melatonin and its possibilities in clinical practice. Melatonin: prospects for clinical use / ed. S.I. Rapoport. Clinical medicine. 2012. No. 8. pp. 73–75.